Terms: = Germ cell tumor AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Staging
18 results:
1. Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
2. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
Piccardo A; Treglia G; Fiz F; Bar-Sever Z; Bottoni G; Biassoni L; Borgwardt L; de Keizer B; Jehanno N; Lopci E; Kurch L; Massollo M; Nadel H; Roca Bielsa I; Shulkin B; Vali R; De Palma D; Cecchin D; Santos AI; Zucchetta P
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):756-767. PubMed ID: 37962616
[TBL] [Abstract] [Full Text] [Related]
3. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
Bender HG; Irwin MS; Hogarty MD; Castleberry R; Maris JM; Kao PC; Zhang FF; Naranjo A; Cohn SL; London WB
J Clin Oncol; 2023 Jun; 41(17):3149-3159. PubMed ID: 37098238
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
Heng X; Chen B; Zhao K; Li J; Wu W; Peng Y; Zhong R
PLoS One; 2023; 18(4):e0284930. PubMed ID: 37093837
[TBL] [Abstract] [Full Text] [Related]
5. Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival.
Demetz M; Krigers A; Moser P; Kerschbaumer J; Thomé C; Freyschlag CF
J Neurooncol; 2023 Apr; 162(2):397-405. PubMed ID: 37043120
[TBL] [Abstract] [Full Text] [Related]
6. Somatostatin receptor activity assessed by
Mapelli P; Bezzi C; Muffatti F; Ghezzo S; Baldassi F; Schiavo Lena M; Andreasi V; Canevari C; Magnani P; De Cobelli F; Gianolli L; Partelli S; Falconi M; Picchio M
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2818-2829. PubMed ID: 37010579
[TBL] [Abstract] [Full Text] [Related]
7. Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.
Soldatelli JS; Oliveira IM; Kneubil MC; Henriques JAP
An Acad Bras Cienc; 2022; 94(3):e20211075. PubMed ID: 35766600
[TBL] [Abstract] [Full Text] [Related]
8. Clinical utility of the AJCC 8
Badia RR; Woldu S; Patel HD; Singla N; Srivastava A; Cheaib JG; Pierorazio PM; Bagrodia A
Urol Oncol; 2021 Feb; 39(2):136.e19-136.e25. PubMed ID: 33353868
[TBL] [Abstract] [Full Text] [Related]
9. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract] [Full Text] [Related]
10. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract] [Full Text] [Related]
11. Grading of Neuroendocrine Carcinomas: Correlation of
Liverani C; Bongiovanni A; Mercatali L; Foca F; Pieri F; De Vita A; Spadazzi C; Miserocchi G; Recine F; Riva N; Nicolini S; Severi S; Martinelli G; Ibrahim T
Dis Markers; 2018; 2018():6878409. PubMed ID: 30627226
[TBL] [Abstract] [Full Text] [Related]
12. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract] [Full Text] [Related]
13. Implementation of the 7th edition AJCC staging system: Effects on staging and survival for pT1 melanoma. A Dutch population based study.
Oude Ophuis CM; Louwman MW; Grünhagen DJ; Verhoef K; van Akkooi AC
Int J Cancer; 2017 Apr; 140(8):1802-1808. PubMed ID: 28109000
[TBL] [Abstract] [Full Text] [Related]
14. Racial and socioeconomic disparities in malignant carcinoid cancer cause specific survival: analysis of the surveillance, epidemiology and end results national cancer registry.
Cheung R
Asian Pac J Cancer Prev; 2013; 14(12):7117-20. PubMed ID: 24460261
[TBL] [Abstract] [Full Text] [Related]
15. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
16. Preoperative imaging for early-stage cutaneous melanoma: predictors, usage, and utility at a single institution.
Haddad D; Garvey EM; Mihalik L; Pockaj BA; Gray RJ; Wasif N
Am J Surg; 2013 Dec; 206(6):979-85; discussion 985-6. PubMed ID: 24124660
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors for scoliosis in children with neuroblastoma.
Paulino AC; Fowler BZ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):865-9. PubMed ID: 15708267
[TBL] [Abstract] [Full Text] [Related]
18. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
[TBL] [Abstract] [Full Text] [Related]
